Task: Answer Verification
Input (English): Question: Does end-of-treatment virologic response predict relapse after lamivudine treatment for chronic hepatitis B?
Answer: Our results suggest that end-of-treatment virologic response cannot predict post-treatment relapse in patients with HBeAg-negative or -positive chronic hepatitis B. The impact of HBV genotype on the response to lamivudine treatment awaits further studies.
Output (English): no